phenylalanine has been researched along with Angiogenesis, Pathologic in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (35.71) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 6 (21.43) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishna, P; George, S; Hatoum, H; Mukherjee, S | 1 |
| Anderson, KC; Chauhan, D; Lewensohn, R; Munshi, N; Paba-Prada, C; Ray, A; Richardson, P; Spira, J; Viktorsson, K | 1 |
| Dale, T; Fryknäs, M; Fuchs, PF; Gerwins, P; Gullbo, J; Larsson, R; Strese, S; Wickström, M | 1 |
| Altieri, S; Aromando, RF; Bortolussi, S; Garabalino, MA; Heber, EM; Itoiz, ME; Molinari, AJ; Monti Hughes, A; Portu, AM; Pozzi, EC; Saint Martin, G; Schwint, AE; Thorp, SI; Trivillin, VA | 1 |
| Kurosawa, T; Matsui, S; Sugimoto, K; Tian, Y; Touma, M; Wu, Q; Xing, Y; Yanai, T | 1 |
| Barsoum, J; Borella, C; Foley, KP; Jiang, J; Korbut, T; Li, H; Sang, J; Sonderfan, AJ; Wu, Y; Ye, J; Zhang, M; Zhang, X; Zhou, D | 1 |
| Chen, QF; Li, D; Wang, HB; Wang, L; Wang, Y | 1 |
| Collen, A; Grimbergen, J; Hanemaaijer, R; Koolwijk, P; Lupu, F; Peters, E; Quax, PH; van Hinsbergh, VW; van Lent, N | 1 |
| Augustin, HG | 1 |
| Buhr, HJ; Foitzik, T; Hines, OJ; Hotz, B; Hotz, HG; Reber, HA | 1 |
| Bergers, G; Hanahan, D | 1 |
| Buesa, JM; de Buitrago, GG; Gómez-Moutón, C; Jiménez-Baranda, S; Lacalle, RA; Mañes, S; Martínez-A, C; Mira, E | 1 |
| Devy, L; Foidart, JM; Frankenne, F; Grams, F; Krell, HW; Maquoi, E; Noël, A; Olivier, F; Sounni, NE | 1 |
| Godlewski, A; Meleń-Mucha, G; Mucha, SA; Stepień, H | 1 |
| Gao, SJ; Qian, LW; Xie, J; Ye, F | 1 |
| Aslakson, CJ; Elstad, CA; Meadows, GG; Starkey, JR | 1 |
| Belotti, D; Borsotti, P; Brown, PD; Drudis, T; Garofalo, A; Giavazzi, R; Scanziani, E; Taraboletti, G | 1 |
| Copeland, J; Gilbertson-Beadling, S; Ledbetter, S; Mitchell, M; Petzold, G; Poorman, R; Powers, EA; Scott, PS; Stamp-Cole, M; Wallace, TL | 1 |
| Brown, PD; Giavazzi, R | 1 |
| Kuwano, M; Ono, M | 2 |
| Dickson, RB; Hawkins, MJ; Wojtowicz-Praga, SM | 1 |
| Bergers, G; Folkman, J; Hanahan, D; Javaherian, K; Lo, KM | 1 |
| Bu, W; Li, XM; Qin, LX; Tang, ZY; Xia, JL | 1 |
| Chambers, AF; Groom, AC; MacDonald, IC; Morris, VL; Schmidt, EE; Varghese, HJ; Wylie, S | 1 |
| Balkwill, FR; Dias, S; Holdsworth, H; Scott, KA | 1 |
| Broxterman, HJ; Gebbink, MF; Hoekman, K; Jorna, AS; Pinedo, HM; Verheul, HM | 1 |
| Duriez, M; Levy, BI; Mallat, Z; Silvestre, JS; Tamarat, R; Tedgui, A | 1 |
6 review(s) available for phenylalanine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Serotonin Pathway in Cancer.
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Neuroendocrine; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Gene Expression Regulation, Neoplastic; Humans; Molecular Targeted Therapy; Neovascularization, Pathologic; Octreotide; Phenylalanine; Pyrimidines; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Signal Transduction; Tryptophan Hydroxylase; Tumor Cells, Cultured | 2021 |
[Angiogenesis research--quo vadis?].
Topics: Adult; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Bevacizumab; Cell Communication; Drug Evaluation, Preclinical; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Ephrins; Forecasting; Growth Substances; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Lymphokines; Metalloendopeptidases; Mice; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Phenylalanine; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Research; Signal Transduction; Thalidomide; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Matrix metalloproteinase inhibition: a review of anti-tumour activity.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Melanoma, Experimental; Metalloendopeptidases; Neovascularization, Pathologic; Phenylalanine; Protease Inhibitors; Thiophenes | 1995 |
[Development of anti tumor agents targeting angiogenesis].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclohexanes; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Hydroxamic Acids; Interferon-alpha; Interleukin-12; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Phenylalanine; Platelet Factor 4; Polysaccharides, Bacterial; Sesquiterpenes; Thalidomide; Thiophenes; Triazines; Triazoles; Tumor Cells, Cultured | 1997 |
Matrix metalloproteinase inhibitors.
Topics: Antineoplastic Agents; Cell Division; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Down-Regulation; Drugs, Investigational; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Hydroxamic Acids; Metalloendopeptidases; Molecular Weight; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Phenylalanine; Protease Inhibitors; Protein Kinase C; Proteins; Thiophenes; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Tissue Inhibitor of Metalloproteinases | 1997 |
[Neovascularization and tumor development].
Topics: Angiostatins; Antibiotics, Antineoplastic; Antineoplastic Agents; Collagen; Cyclohexanes; Endostatins; Humans; Hydroxamic Acids; Interferons; Interleukin-12; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Peptide Fragments; Phenylalanine; Plasminogen; Sesquiterpenes; Thalidomide; Thiophenes | 1998 |
22 other study(ies) available for phenylalanine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
In vitro and in vivo antitumor activity of a novel alkylating agent, melphalan-flufenamide, against multiple myeloma cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Movement; Cell Survival; Disease Models, Animal; Drug Synergism; Female; Humans; Melphalan; Mice; Multiple Myeloma; Neovascularization, Pathologic; Phenylalanine; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Animals; Cattle; CD13 Antigens; Chick Embryo; Chorioallantoic Membrane; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Melphalan; Mice; Neovascularization, Pathologic; Phenylalanine; Prodrugs | 2013 |
Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cricetinae; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Phenylalanine; Precancerous Conditions; Thalidomide | 2015 |
CCL11-induced eosinophils inhibit the formation of blood vessels and cause tumor necrosis.
Topics: Animals; Cell Line, Tumor; Chemokine CCL11; Endothelial Cells; Eosinophils; Fibrosarcoma; Granulocytes; Mice; Naphthalenes; Neovascularization, Pathologic; Phenylalanine; Receptors, CCR3 | 2016 |
The vascular disrupting agent STA-9584 exhibits potent antitumor activity by selectively targeting microvasculature at both the center and periphery of tumors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Cell Survival; Dogs; Female; Heart; Hemodynamics; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Isoxazoles; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Microcirculation; Neoplasms; Neovascularization, Pathologic; Phenylalanine; Rabbits; Regional Blood Flow; Tubulin Modulators; Xenograft Model Antitumor Assays | 2012 |
Mesothelin promotes invasion and metastasis in breast cancer cells.
Topics: Animals; Breast Neoplasms; Butadienes; Cell Line, Tumor; Cell Movement; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Lymphatic Metastasis; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; MCF-7 Cells; Mesothelin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; Nitriles; Phenylalanine; Protease Inhibitors; Thiophenes; Transplantation, Heterologous | 2012 |
Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
Topics: Adenoviridae; Aprotinin; Cells, Cultured; Collagen; Culture Media; Defective Viruses; Drug Synergism; Endothelial Growth Factors; Endothelium, Vascular; Fibrin; Fibroblast Growth Factor 2; Genetic Vectors; Heart Diseases; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phenylalanine; Protease Inhibitors; Thiophenes; Thrombosis; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-3; Transduction, Genetic; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Chi-Square Distribution; Disease Models, Animal; Drug Therapy, Combination; Endothelial Growth Factors; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Matrix Metalloproteinases; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms; Phenylalanine; Probability; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Islet Cell; Chronotherapy; Indoles; Matrix Metalloproteinase Inhibitors; Mice; Neovascularization, Pathologic; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Thiophenes | 2002 |
Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Dipeptides; Doxycycline; Enzyme Activation; Humans; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Microdomains; Membrane Proteins; Neovascularization, Pathologic; Phenylalanine; Protein Binding; Protein Transport; Receptors, LDL; Recombinant Fusion Proteins; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2004 |
Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Aorta; Breast Neoplasms; Cell Line, Tumor; Disease Progression; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Microscopy, Fluorescence; Models, Chemical; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; Phenylalanine; Piperazines; Protease Inhibitors; Pyrimidines; Rats; Thiophenes; Time Factors; Up-Regulation | 2004 |
Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Diethylstilbestrol; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Estrogens; Image Processing, Computer-Assisted; Male; Metalloendopeptidases; Neovascularization, Pathologic; Organ Size; Phenylalanine; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactinoma; Proliferating Cell Nuclear Antigen; Protease Inhibitors; Rats; Rats, Inbred F344; Thiophenes | 2007 |
Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.
Topics: Autocrine Communication; Cell Transformation, Viral; Cells, Cultured; Collagenases; Endothelial Cells; Gene Expression Regulation, Enzymologic; Herpesvirus 8, Human; Humans; Neoplasm Invasiveness; Neovascularization, Pathologic; Paracrine Communication; Phenylalanine; Protease Inhibitors; Response Elements; RNA, Messenger; RNA, Neoplasm; Sarcoma, Kaposi; Thiophenes; Transcription Factor AP-1; Umbilical Veins; Up-Regulation | 2007 |
Evidence for nutrient modulation of tumor phenotype: impact of tyrosine and phenylalanine restriction.
Topics: Animal Nutritional Physiological Phenomena; Animals; Diet; Female; Killer Cells, Natural; Lung; Mast Cells; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Phenotype; Phenylalanine; Tumor Cells, Cultured; Tyrosine | 1994 |
Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
Topics: Animals; Dose-Response Relationship, Drug; Female; Hemangioendothelioma; Metalloendopeptidases; Mice; Neoplasm Invasiveness; Neovascularization, Pathologic; Phenylalanine; Thiophenes; Time Factors | 1995 |
The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism.
Topics: Animals; Aorta; Doxycycline; Gelatinases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Minocycline; Neoplasm Proteins; Neovascularization, Pathologic; Phenylalanine; Rats; Rats, Inbred F344; Thiophenes | 1995 |
Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.
Topics: Angiostatins; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Islet Cell; Collagen; Cyclohexanes; Disease Progression; Drug Evaluation, Preclinical; Endostatins; Female; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Staging; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Pancreatic Neoplasms; Peptide Fragments; Phenylalanine; Plasminogen; Sesquiterpenes; Thiophenes | 1999 |
Effect of antiangiogenic agents on experimental animal models of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Cell Division; Cyclohexanes; Liver Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Phenylalanine; Sesquiterpenes; Suramin; Thiophenes; Triazoles | 1999 |
The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells.
Topics: Animals; Cell Movement; Cell Survival; Injections, Intraperitoneal; Injections, Intravenous; Liver Neoplasms; Melanoma, Experimental; Mesenteric Veins; Mice; Microscopy, Video; Neovascularization, Pathologic; Phenylalanine; Thiophenes; Tumor Cells, Cultured | 1999 |
Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Female; Interleukin-12; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phenylalanine; Protease Inhibitors; Thiophenes | 2000 |
Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets.
Topics: Adult; Blood Platelets; Cell Division; Cells, Cultured; Endothelial Growth Factors; Endothelium, Vascular; Fibroblast Growth Factor 2; Flow Cytometry; Humans; Lymphokines; Microscopy, Fluorescence; Neoplasms; Neovascularization, Pathologic; Phenylalanine; Piperidines; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Thrombin; Thrombophilia; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis.
Topics: Angiography; Animals; Blood Flow Velocity; Capillaries; Disease Models, Animal; Endothelial Growth Factors; Enzyme Activation; Femoral Artery; Fibroblast Growth Factor 2; Hindlimb; Interleukin-10; Ischemia; Laser-Doppler Flowmetry; Lymphokines; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Phenylalanine; Platelet Endothelial Cell Adhesion Molecule-1; Protease Inhibitors; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |